Author Question: How would the technologist differentiate between a traumatic specimen collection tap and a cerebral ... (Read 18 times)

hbsimmons88

  • Hero Member
  • *****
  • Posts: 526
How would the technologist differentiate between a traumatic specimen collection tap and a cerebral hemorrhage? Provide at least three macroscopic and three microscopic findings.
 
  What will be an ideal response?

Question 2

Which type of fluid is milky in appearance and is formed from long-standing effusions resulting from chronic conditions?
 
  a. Transudate
  b. Pseudochylous
  c. Exudates
  d. Chylous



FergA

  • Sr. Member
  • ****
  • Posts: 352
Answer to Question 1

nswer:
Macroscopic findings: traumatic tap
 Decreasing gross blood in subsequent tubes; highest concentration of gross blood typically present in Tube 1with subsequent decreasing numbers in the remaining tubes
 The presence of a clot in the sample; trauma to the body introduced by specimen collection, activating the coagulation cascade
 The absence of xanthochromia. Xanthochromia indicating hemoglobin breakdown
Macroscopic findings: cerebral hemorrhage
 Equal concentration of blood in all four tubes
 No clot present in the sample
 Presence of xanthochromia in the sample
Microscopic findings: traumatic tap
 Intact RBCs in high numbers
 No ingestion of RBCs by phagocytic cells
 No hematoidin/hematin crystals present
 No hemosiderin crystals present
Microscopic findings: cerebral hemorrhage
 RBCs fragments often seen
 Erythrophagocytosis present
 Hemosiderin present
 Hematoidin/hematin crystals present

Answer to Question 2

Correct Answer: B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In 1885, the Lloyd Manufacturing Company of Albany, New York, promoted and sold "Cocaine Toothache Drops" at 15 cents per bottle! In 1914, the Harrison Narcotic Act brought the sale and distribution of this drug under federal control.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

Approximately 70% of expectant mothers report experiencing some symptoms of morning sickness during the first trimester of pregnancy.

Did you know?

Most childhood vaccines are 90–99% effective in preventing disease. Side effects are rarely serious.

For a complete list of videos, visit our video library